title: Henoch-Schönlein purpura after intravesical administration of bacillus Calmette-Guérin.
abstract: The administration of intravesical bacille Calmette-Guérin (BCG) in early stages of bladder cancer is usually a safe therapy. Side-effects of BCG immunotherapy can be of both local and systemic nature. We report the first case of Henoch-Schönlein purpura following intravesical administration of BCG.
authors.affiliation: Department of Internal Medicine, University Hospital Marqués de Valdecilla, ES-39008 Santander, Spain.
authors.forename: Daniel N
authors.initials: DN
authors.lastname: Nan
authors.forename: Marta
authors.initials: M
authors.lastname: Fernández-Ayala
authors.forename: Carmen
authors.initials: C
authors.lastname: García-Ibarbia
authors.forename: Mar
authors.initials: M
authors.lastname: Gutiérrez-Santiago
authors.forename: José L
authors.initials: JL
authors.lastname: Hernández
mesh_terms: D000283:Administration, Intravesical; D000368:Aged; D006801:Humans; D011695:IgA Vasculitis / Q000209:etiology* / Q000503:physiopathology; D008297:Male; D009163:Mycobacterium bovis / Q000472:pathogenicity*; D001749:Urinary Bladder Neoplasms / Q000628:therapy